We are on our way to Montreal for the first annual Common Sense Oncology annual meeting. Makes me nostalgic to share this video from 5 years ago from a talk I did at CADTH .

youtu.be/dNFga1iQ4B4?si…

⚠️Call for Patient and Clinician Input⚠️ We are requesting input on exagamglogene autotemcel for transfusion-dependent beta-thalassemia.

Deadline is May 13, 2024: cadth.ca/exagamglogene-… #HTA

“We can’t do our work without patient and community engagement. They are essential and provide input into our reimbursement submissions and on advisory committees.”

– Sudha Kutty at the National Pain Congress held during the
Canadian Pain Society Society Annual Scientific Meeting.

⚠️Call for Patient and Clinician Input⚠️ We are requesting input on rozanolixizumab for generalized myasthenia gravis (gMG).

Deadline is May 13, 2024: cadth.ca/rozanolixizumab #HTA

⚠️Call for Patient and Clinician Input⚠️ We are requesting input on ferric carboxymaltose for iron deficiency #anemia .

Deadline is May 7, 2024: cadth.ca/ferric-carboxy… #HTA

🔔 Reminder! We are now accepting late-breaking abstracts for early morning sessions, workshops, and panels, as well as oral and poster presentations for Symposium 2024.

📆 Deadline is 5 p.m. ET on Friday, May 10

To learn more about eligibility, visit: cadth.ca/call-late-brea…

⚠️Call for Patient and Clinician Input⚠️ We are requesting input on avapritinib for advanced systemic mastocytosis.

Deadline is May 7, 2024: cadth.ca/avapritinib #HTA

Sudha Kutty, our Executive Vice-President, Evidence, Products, and Services, will participate on a panel about medications and chronic pain at the National Pain Congress on April 29, 2024, held during the Canadian Pain Society Society Annual Scientific Meeting. 👇

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on ciltacabtagene autoleucel ( #Carvykti ) for relapsed or refractory multiple myeloma.

Deadline is April 30, 2024: cadth.ca/ciltacabtagene… #HTA

Request for Standing Offers 📋

This RFSO is duplicative of the previous RFSO for PMDE and is intended to allow for additional time to apply, with a deadline of May 2, 2024. 

Learn more: cadth.ca/request-standi…

We're pleased to share Partnering for Results, our 2023–2024 Annual Report.

This past year, our focus on collaboration has helped us forge new connections and strengthen existing relationships, achieving more together than we ever could alone.

👉 loom.ly/L45C5y0

We are now accepting late-breaking abstracts for early morning sessions, workshops, and panels, as well as oral and poster presentations for Symposium 2024.

📆 Deadline is 5 p.m. ET on Friday, May 10, 2024

To learn more about eligibility, visit: cadth.ca/call-late-brea…

⚠️Call for Patient and Clinician Input⚠️ CADTH is requesting input on alectinib ( #Alecensaro ) for ALK-positive #NSCLC .

Deadline is April 30, 2024: cadth.ca/alectinib #HTA #PatientInput #ClinicianInput

This week is #NOTDAW , National Organ and Tissue Donation Awareness Week. Explore our new interactive web page for Canada’s organ donation and transplantation data today.

Learn more: ow.ly/TBQz50Rk9JQ

#OrganDonation #Transplantation